Crossmark Global Holdings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.6M | Buy |
53,183
+646
| +1% | +$240K | 0.27% | 84 |
|
|
2026
Q1 | $15.4M | Sell |
52,537
-2,857
| -5% | -$939K | 0.23% | 106 |
|
|
2025
Q4 | $19.4M | Buy |
55,394
+3,392
| +7% | +$1.15M | 0.28% | 78 |
|
|
2025
Q3 | $16.8M | Sell |
52,002
-1,503
| -3% | -$467K | 0.25% | 95 |
|
|
2025
Q2 | $20.8M | Buy |
53,505
+31,802
| +147% | +$12.8M | 0.34% | 65 |
|
|
2025
Q1 | $9.44M | Sell |
21,703
-112
| -0.5% | -$45K | 0.17% | 153 |
|
|
2024
Q4 | $8.05M | Sell |
21,815
-669
| -3% | -$280K | 0.15% | 164 |
|
|
2024
Q3 | $11.7M | Sell |
22,484
-16,261
| -42% | -$8.69M | 0.21% | 121 |
|
|
2024
Q2 | $21M | Sell |
38,745
-9,553
| -20% | -$5.05M | 0.4% | 54 |
|
|
2024
Q1 | $25M | Sell |
48,298
-1,957
| -4% | -$973K | 0.48% | 43 |
|
|
2023
Q4 | $23.7M | Buy |
50,255
+427
| +0.9% | +$197K | 0.49% | 35 |
|
|
2023
Q3 | $22.7M | Sell |
49,828
-23,402
| -32% | -$10.6M | 0.51% | 34 |
|
|
2023
Q2 | $34.2M | Buy |
73,230
+1,630
| +2% | +$752K | 0.74% | 16 |
|
|
2023
Q1 | $32.9M | Buy |
71,600
+24,219
| +51% | +$11.5M | 0.77% | 12 |
|
|
2022
Q4 | $24.3M | Buy |
47,381
+1,748
| +4% | +$888K | 0.61% | 23 |
|
|
2022
Q3 | $20.7M | Buy |
45,633
+787
| +2% | +$377K | 0.58% | 25 |
|
|
2022
Q2 | $21.6M | Buy |
44,846
+3,572
| +9% | +$1.77M | 0.56% | 26 |
|
|
2022
Q1 | $20.3M | Buy |
41,274
+9,189
| +29% | +$4.2M | 0.45% | 37 |
|
|
2021
Q4 | $14.9M | Sell |
32,085
-3,304
| -9% | -$1.39M | 0.32% | 69 |
|
|
2021
Q3 | $13.2M | Buy |
35,389
+10,901
| +45% | +$4.14M | 0.31% | 78 |
|
|
2021
Q2 | $9.35M | Buy |
24,488
+2,081
| +9% | +$795K | 0.22% | 116 |
|
|
2021
Q1 | $8.04M | Sell |
22,407
-1,483
| -6% | -$477K | 0.2% | 129 |
|
|
2020
Q4 | $7.67M | Sell |
23,890
-2,874
| -11% | -$882K | 0.19% | 131 |
|
|
2020
Q3 | $7.19M | Buy |
26,764
+2,629
| +11% | +$707K | 0.2% | 129 |
|
|
2020
Q2 | $6.35M | Buy |
24,135
+2,503
| +12% | +$668K | 0.19% | 135 |
|
|
2020
Q1 | $4.91M | Buy |
21,632
+1,041
| +5% | +$284K | 0.18% | 143 |
|
|
2019
Q4 | $6.22M | Sell |
20,591
-328
| -2% | -$90.3K | 0.17% | 145 |
|
|
2019
Q3 | $5.02M | Buy |
20,919
+397
| +2% | +$109K | 0.15% | 170 |
|
|
2019
Q2 | $5.79M | Buy |
20,522
+1,470
| +8% | +$402K | 0.16% | 150 |
|
|
2019
Q1 | $5.47M | Sell |
19,052
-2,071
| -10% | -$599K | 0.16% | 162 |
|
|
2018
Q4 | $5.55M | Sell |
21,123
-907
| -4% | -$249K | 0.17% | 151 |
|
|
2018
Q3 | $6.04M | Sell |
22,030
-671
| -3% | -$174K | 0.15% | 155 |
|
|
2018
Q2 | $5.4M | Sell |
22,701
-666
| -3% | -$154K | 0.15% | 173 |
|
|
2018
Q1 | $5.13M | Sell |
23,367
-1,592
| -6% | -$374K | 0.13% | 190 |
|
|
2017
Q4 | $5.62M | Sell |
24,959
-9,147
| -27% | -$1.95M | 0.13% | 187 |
|
|
2017
Q3 | $6.48M | Buy |
+34,106
| New | +$6.49M | 0.17% | 149 |
|
|
2016
Q3 | $6.48M | Buy |
+34,106
| New | +$4.4M | 0.17% | 149 |
|
Other funds holding ELV
Crossmark Global Holdings's ELV Position: Q2 2026 in Review
Crossmark Global Holdings increased its Elevance Health (ELV) stake by 1.2% in Q2 2026, buying an estimated $240K and bringing the position to 53,183 shares worth $20.6M. The position accounts for 0.27% of the portfolio, ranked #84.
Crossmark Global Holdings first reported a position in ELV in Q3 2016 and has held it in 37 quarters since. The position peaked at $34.2M in Q2 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Crossmark Global Holdings held 53,183 shares of Elevance Health worth $20.6M as of Q2 2026.
- Crossmark Global Holdings bought 646 Elevance Health shares in Q2 2026, an estimated $240K.
- Elevance Health made up 0.27% of Crossmark Global Holdings's portfolio in Q2 2026, its #84 holding.
- Crossmark Global Holdings first reported a position in Elevance Health in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Elevance Health position peaked at $34.2M in Q2 2023.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.